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Abstract: A DNA fragment encoding C-terminal BARc region (amino acids 128-416) of 
rat PICK1 (NP_445912 ) was inserted into a modified vector pMAL-s involving human 
rhinovirus 3C protease cleavage site to produce a recombinant plasmid, pMAL-s-barc. 
The construct can express the fusion protein, MBP-BARc in the soluble form in E.coli. 
To remove the MBP tag, MBP-BARc purified from amylose beads was digested with 
human rhinovirus 3C protease and the cleavage efficiency is about 95% when the ratio of 
protein / enzyme (w/w) reaches 50:1, as analyzed on SDS-PAGE. The enzymatic reaction 
mixture was rapidly separated into two parts, MBP in the supernatant and BARc in the 
precipitate at the concentration of 1 M ammonium sulfate. In such case, the target protein 
BARc could be economically produced in a soluble state to be as the sample for 
measuring its biochemical function, for example, protein-protein interaction and 
protein-lipid combination. 
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1. Introduction 
 
PICK1 (protein interacting with C kinase 1) is a protein kinase C (PKC) binding protein, initially 
identified by a yeast two-hybrid system [1]. It is a cytosolic protein containing a PDZ [postsynaptic 
density-95 (PSD-95)/Discs large/zona occludens-1] domain at N-terminus as well as a BAR 
(Bin/amphysin/Rvs) domain and an acidic amino acid region close to the C-terminus [2]. The PICK1 
PDZ domain (amino acids 20-110) was shown to mediate
 the interaction with a broad range of proteins 
including receptor
 tyrosine kinases, ionotropic glutamate receptors of the L-α-amino-3-hydroxy-5- 
methyl-4-isoxazole propionic acid (AMPA) and kainate subtypes, metabotropic glutamate
 receptors, 
ion channels, G protein-coupled receptors,
 transmembrane transporters and ADP-ribosylation factors 
[2-5]. PICK1 BAR domain (amino acids 152-362) has an action of protein trafficking, especially 
endocytosis. The BAR domain of amphiphysin can directly bind and tubulate to liposomes [6]. It was 
reported that the amino acid sequence conservation among BAR domains from Endophilin, 
Amphiphysin and Arfaptin was quite low [6-8]. When the BAR domain is expressed in E. coli, the 
recombinant product frequently forms an aggregate. Therefore, the biochemical function of BAR 
domain has been rarely reported. In order to explore the biological function of BAR domain in rat 
PICK1 (NP_445912), we prepared a soluble fusion protein MBP-BARc and then, obtained the target 
protein BARc (amino acids 128-416). In this report, we constructed a new vector pMAL-s, which is 
modified from pMAL- p2X by substituting Factor Xa cleavage site with human rhinovirus 3C protease 
cleavage site. In such case, the expression product, MBP-BARc could be cleaved into MBP and BARc 
by the protease. However, it is still hard to separate the target product BARc from the enzymatic 
mixture by either ion-exchange chromatography or gel filtration due to its aggregate. After exploring 
some methods, an unexpected finding was that the BARc in the enzyme reaction mixture could be 
easily separated by ammonium sulfate precipitation. The finding provides a convenience for further 
studying the biological function of the BARc [9].   
 
2. Materials and methods 
 
2.1. Bacterial strains, plasmid and reagents 
 
E.coli DH5α, E.coli JM109 and E.coli BL21 strains stored in this laboratory were used as host cells 
for cloning and expression. In addition, a recombinant strain was used to produce human rhinovirus 3C 
protease. Vector pMAL-p2X, amylose beads and restriction enzymes were all from New England 
Biolabs (Beverly, MA, USA). Bovine brain lipid extracts (Type I, Folch Fraction I,) was from 
Sigma-Aldrich Co. (St. Louis, MO, USA). The recombinant plasmid pRK5-pick1 was a gift from Dr. 
MJ. Zhang (Department of Biochemistry, HKUST). An anti-BARc polyclonal antibody used was 
prepared by this research group.  The human rhinovirus 3C protease was expressed and purified as 
described in reference [10]. The secondary antibody, rabbit anti-guinea pig immunoglobulin G 
conjugated horseradish peroxidase (HRP) was purchased from Boda Biotech. Co. (Beijing, P.R. China). 
All other chemicals used were commercially available. 
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2.2. Construction of recombinant plasmid pMAL-s-barc 
 
A pair of chemically synthesized oligo-nucleotides containing human rhinovirus 3C protease 
cleavage site (5′-CTCGGGCTGGAAGTTCTGTTCCAGGGTCCGCTGGGTACCCCGG-3′, and 
5′-GAATTCCGGGGTACCCAGCGGACCCTGGAACAGAACTTCCAGC-3′) was annealed. Then, 
the dsDNA oligo-nucleotide was inserted into pMAL-p2X vector where the Factor Xa cleavage site 
was already deleted via EcoRI and SalI restriction sites to produce a modified vector pMAL-s. 
Therefore, the vector contains human rhinovirus 3C protease cleavage site (Figure 1). The gene 
sequence of the BARc was amplified by PCR with pRK5-pick1 as the template in the presence of the 
forward primer 5’-CGGAATTCATGAGTTCAGGCACAG-3’and reverse primer 
5’-GGGGGTCGACTCA- GGAGTCACACCAGC-3’ (EcoR I and Sal I sites are black). Finally, the 
PCR product was cloned into pMAL-s vector via EcoR I and Sal I restriction sites to generate the 
recombinant plasmid pMAL-s-barc. Both pMAL-s and pMAL-s-barc plasmids were verified by DNA 
sequencing. 
 
Figure 1. A diagrammatic map of pMAL-s. The Factor Xa cleavage site in pMAL-p2X is 
replaced with human rhinovirus 3C protease cleavage site. 
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2.3. Expression and purification of fusion protein, MBP-BARc   
 
Escherichia coli strain JM109 was transformed with pMAL-s-barc and grown at 37 °C in 10 mL 
LB medium supplemented with 100 μg/mL ampicillin. The overnight culture was inoculated into one 
liter LB medium supplemented with 100 μg/mL ampcillin and grown under the same conditions. When 
cell OD600 reached 0.6-0.7, IPTG was added to a final concentration of 0.5 mM to induce the protein 
expression and cells were further cultured for 4 h in the same condition. The bacterial pellet was 
suspended in lysis buffer (40 mL, 20 mM Tris-HCl buffer, pH 8.0, containing 100 mM NaCl), 
followed by a sonication procedure. The mixture was centrifuged at 10,000 g for 30 min. The 
supernatant was directly loaded onto amylose beads pre-equilibrated with 20 mM Tris-HCl buffer, pH 
8.0 containing 100 mM NaCl. The captured MBP-BARc beads were thoroughly washed with the same 
buffer to remove non-specifically bound proteins and the fusion protein was eluted with the same 
buffer containing 10 mM maltose. The purity of the MBP-BARc was determined by SDS-PAGE using 
12% polyacrylamide gel. The protein concentration was estimated by Bradford method with BSA as 
the standard. 
 
2.4. Removal of the affinity tag and separation of the BARc   
 
The affinity tag in fusion protein MBP-BARc can be cleaved by human rhinovirus 3C protease at 
the weight ratio of 50:1 (substrate/enzyme) at RT for 20 h. Then, the solid (NH4)2SO4 was slowly 
added to the reaction mixture until reaching 1 M. The mixture then was centrifuged at 10,000g for 30 
min. The tag MBP was kept in the supernatant and the target protein BARc was remained in the 
precipitate. The BARc precipitate was dissolved with the buffer (50 mM Tris-HCl, 150 mM NaCl, 
pH7.2) and dialyzed against the same buffer for next step. 
 
2.5. Western-blot analysis of BARc domain 
 
Protein samples were run on SDS-PAGE and transferred to nitrocellulose membrane. Non-specific 
binding sites of the protein were blocked with 1% (w/v) skimmed milk in PBS. The membrane 
harboring the sample was incubated with guinea pig anti-BARc polyclonal primary antibody and in 
turn, with the secondary rabbit anti-guinea pig antibody conjugated with horseradish peroxidase (HRP). 
Finally, the immuno-conjugate was visualized by 3,3’-diaminobenzidine tetrahydrochloride solution [11] . 
 
2.6. Interaction of PDZ and BARc domains identified by the Pull-down test 
 
An aliquot of Ni
2+-NTA agarose beads harboring about 20 μg PDZ domain were mixed with 
different amounts (0, 25, 50, 100 μg) of the soluble BARc domain in total 500 μl buffer and incubated 
for 2 h at 4 ºC. Each sample was washed five times with 1 mL buffer (50 mM Tris-HCl, 150 mM NaCl, 
5mM imidazole, pH7.5) until no protein was detected in the washing solution. Finally, the captured 
resin was suspended in 20 μL loading buffer and analyzed on SDS-PAGE. 
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2.7. Protein Lipid Overlay (PLO) assay 
 
Serial amounts of bovine brain lipid extracts (200, 20, 2 and 0.2 ng) were spotted onto a 
nitrocellulose membrane and blocked with 2% (w/v) BSA in PBS. Then, the membrane was incubated 
with 100 nM MBP, MBP-BARc and BARc at room temperature for 2 h, respectively. After being 
thoroughly washed with PBS buffer, the protein-lipid complex on the membrane was detected by the 
immunological assay as described as Western blot analysis. 
 
3. Results and Discussion 
 
3.1. Expression and purification of fusion protein MBP-BARc   
 
Attempting to express a soluble BARc, we constructed different expression vectors involving 
pET-barc with the vector pET32a, pG-barc with pGEX-6p-1, pH-barc with pHGB and pMAL-s-barc 
with  pMAL-s etc. Unfortunately, although each reconstruct could more and less express the 
corresponding protein MBP-BARc, all of them existed in the precipitate except pMAL-s-barc in E.coli. 
In such case, our experiment was locked on the fusion protein, MBP-BARc. It is shown from 
SDS-PAGE analysis that the cell lysate dominantly reveals a 74 kDa band (Figure 2, A. Lane 2), 
corresponding 42 kDa MBP plus 32 kDa BARc. The yield of the fusion protein is about 35% of total 
proteins in cells, as detected by Gel Document Scanning (GDS). The fusion protein, MBP-BARc was 
further confirmed by Western blot analysis with either anti-MBP monoclonal antibody or anti-BARc 
polyclonal antibody (Figure 2. B). Based on MBP affinity, the supernatant from cell lysate can be 
directly loaded on amylose beads. MBP-BARc may be tightly harbored to amylose beads and eluted 
with the buffer including 10 mM maltose, whilst non-specific proteins were thoroughly washed out by 
the buffer only. The fusion protein purified is quite pure as shown in Figure 2 (A. Lane3). In the 
routine experiment, about 40-50 mg target protein could be obtained in 1 L culture by one-step affinity 
chromatography. It is worthily stressed that not only MBP is as an affinity tag in the fusion expression, 
but also is effective in facilitating or increasing the soluble expression of most recombinant proteins in 
E.coli [11]. 
 
Figure 2. SDS-PAGE analysis and Western blotting of MBP-BARc. (A) SDS-PAGE  M: 
Protein marker; Lane1: un-induced cell lysate; Lane 2: induced cell lysate; Lane 3: product 
eluted from the amylose column; (B) Western blotting.   
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3.2. Removal of the affinity tag from MBP-BARc 
 
To remove the affinity tag from fusion protein MBP-BARc, an enzymatic cleavage procedure was 
conducted with human rhinovirus 3C protease under the condition as described in the Materials and 
Methods section. The result indicated from a gradient time test in Figure 3 that during human 
rhinovirus 3C protease cleavage, the BARc (about 32 kDa) was gradually released from the fusion 
product (about 74 kDa) until 20 h or so. The efficiency of removing MBP tag was about 95%, as 
analyzed by SDS-PAGE (Figure 3). The GDS analysis pointed out that the amount of BARc released 
from the fusion protein was in direct proportion with human rhinovirus 3C protease cleavage time. The 
result implies that the human rhinovirus 3C protease, a bench preparation, can efficiently cleave the 
corresponding tag fused to the target protein.   
 
Figure 3. SDS-PAGE analysis for the gradient time test of MBP-BARc cleaved by human 
rhinovirus 3C protease. M: Protein marker; 0-20 h indicate the reaction time; Labeled 
bands correspond to MBP-BAR (74 kDa), MBP (42 kDa) and BARc (32 kDa) respectively. 
 
 
3.3. Separation of the BARc from the human rhinovirus 3C protease reaction mixture 
 
To separate the BARc from the enzymatic mixture of MBP-BARc, some methods such as ion 
exchange chromatography, gel filtration and even amylose re-affinity were attempted. Unfortunately, 
none was successful due to the aggregate of the sample, either BARc or MBP. In such case, we tried a 
classic method of ammonium sulfate precipitation and unexpectedly found that the BARc could be 
precipitated at 0.2-1.2 M (NH4)2SO4, while MBP was still soluble. The phenomenon may mean that the 
different aggregate state of MBP and BARc results in the different hydration shell round each protein. 
Finally, we used the concentration of 1.0 M (NH4)2SO4 to successfully separate the BARc from the 
enzymatic mixture. The BARc purity in the precipitate is about 95%, as analyzed by SDS-PAGE 
(Figure 4). Although the resoluble BARc may be contaminated with traces of MBP-BARc, it could be 
used as a sample for its functional tests.   
 
3.4. Protein-protein interaction identified by Pull-down test 
 
Pull-down test is based on an immobilized partner which can be combined with its versus ligand. 
Therefore, the protein-protein interaction may be examined by some methods such as SDS-PAGE, 
Western blotting, auto-radiography or mass spectrometry and so on [12]. In this report, Int. J. Mol. Sci. 2009, 10    
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PDZ-Ni
2+-agarose prepared by our group was as one partner and the soluble BARc was as versus 
partner to examine their interaction. It is shown from SDS-PAGE analysis in Figure 5 that the 
interaction between two proteins reveals two bands, corresponding to BARc (32 kDa) and PDZ 
domain (12kDa). Moreover, the dose-dependence of BARc concentration (Figure 5 Lane 2-4) has 
obviously occurred.   
 
Figure 4. SDS-PAGE analysis of purified MBP-BARc, MBP and BARc. M: Protein 
marker; Lane 1: MBP-BARc; Lane 2: MBP-BARc cleaved by human rhinovirus 3C 
protease; Lane 3: MBP in the supernatant of 1.0 M (NH4)2SO4; Lane 4 and 5: re-soluble 
BARc in the precipitate at 1.0 M (NH4)2SO4. 
 
 
Figure 5. Interaction between PDZ domain and the BARc by the Pull-down test. M: 
Protein marker; Lane 1: PDZ domain ( 12 kDa); Lane 2-4: the captured PDZ resin was 
mixed with 25, 50, 100 μg BARc respectively; Lane 5: BARc only (32 kDa). 
 
 
3.5. Combination of the BARc with lipid by PLO assay 
 
The Protein Lipid Overlay (PLO) assay is frequently used to detect a special protein combined with 
lipids [13]. It was reported that PICK1 BAR domain with different lengths could bind to lipids [14]. 
Here we tried to use lipid extracts from bovine brain to evaluate the binding ability of the BARc. The 
result shows in Figure 6 that the developing color degree of the BARc is much deeper than that of 
MBP-BARc, while MBP alone is colorless in the same condition, meaning that the interaction between 
the BARc and lipid has occurred. 
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Figure 6. PLO assay for the BARc. The amount of bovine brain lipid extracts was 
indicated in the top. 100 nM MBP, MBP-BARc and BARc were used respectively. 
 
 
4. Conclusions 
 
In conclusion, we report here for the first time that the PICK1 BARc domain can be successfully 
expressed as MBP-BARc fusion protein in E.coli. Cleavage with human rhinovirus 3C protease and 
subsequent ammonium sulfate precipitation were essential to produce a soluble BARc. This way, the 
target protein BARc domain could be prepared economically at a higher yield. The recombinant BARc 
prepared herein could be as a sample to investigate its biochemical function. We are believed that this 
study may provide a new thought for the protein purification in the field of protein engineering. 
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